NFIL Initiated with BUY Rating and Rs 9,040 Target by Axis Securities

BUY Rating | Target Price: Rs 9,040 | Current Market Price: Rs 8,220

Reader Takeaway: Strong revenue growth projected; advanced materials offer future margin expansion.

What just happened

Axis Securities has initiated coverage on NFIL with a 'BUY' rating and set a target price of Rs 9,040. This implies an upside potential of approximately 10% from the current market price of Rs 8,220. The brokerage forecasts a top-line Compound Annual Growth Rate (CAGR) of 20–25% and anticipates annual capital expenditure between Rs 700 Cr and Rs 1,000 Cr for FY28-30.

Why this matters

This positive initiation by a prominent brokerage signals investor confidence in NFIL's future growth prospects. The target price and BUY recommendation suggest potential for stock appreciation. The focus on high-margin segments like Advanced Materials and CDMO, along with planned capacity expansions, indicates a strategy geared towards enhanced profitability.

The backstory

NFIL is strategically expanding into new, high-margin verticals. The Advanced Materials business targets sectors like Data Centers, Electronics, Defence, and Semiconductors, aiming to contribute 10–15% of total revenue by 2030. The company also has a robust pipeline in its Contract Development and Manufacturing Organization (CDMO) business, with several molecules nearing FDA approval and a significant capacity expansion underway.

What changes now

With the BUY rating and increased target price, NFIL may attract more investor interest. The company's guided investments in new product development and capacity enhancements are expected to drive future earnings. The brokerage highlights NFIL as a credible alternative to Chinese supply chains in the advanced materials space.

Risks to watch

Key execution milestones include the commissioning of new capacities, FDA approvals for CDMO molecules, and the successful ramp-up of the advanced materials vertical. The company's ability to manage its capital expenditure effectively while achieving its growth targets will be crucial.

Peer comparison

While specific peer financial data is not provided in this filing, NFIL's strategic diversification into advanced materials and CDMO aims to differentiate it from traditional specialty chemical players, potentially commanding higher valuations.

Context metrics (time-bound)

• Capex Guidance: Rs 700 Cr annually for the current year, with Rs 700 Cr – Rs 1,000 Cr annually for FY28-30.
• CDMO Revenue Target: $100 Mn by FY27.
• Advanced Materials Revenue Share: 10–15% of total revenue by 2030.
• HPP Capacity: 15,000 MTPA of R32 on track for Q3FY27 commissioning.

What to track next

Investors should closely monitor the progress of the R32 HFC capacity commissioning and the pipeline development in the CDMO segment. The successful penetration into the advanced materials market and management's execution of its capital allocation strategy will be key indicators.